Why We Are Doing This Slowly, and On Purpose

There's a version of Luveda Care that would already be on shelves. It would have been a white-label formula from a catalog, relabeled with our name, produced overseas in a single large run, and shipped to a warehouse to sit until it sold. That path is well worn because it works. You can go from idea to product in a few months, the cost per jar drops sharply, and nobody in the supply chain asks you difficult questions.

We didn't take it, and the result is that we're launching in October with one product instead of last year with five. Here's the reasoning, because "we're small batch" has become the kind of phrase brands say without explaining, and a claim you can't explain isn't worth much.

What small batch actually means for us

Small batch is a description of production size, not a quality certificate. Nobody audits the term and no regulator defines it, so any brand can print it on a label. What it means in our case is that we produce a limited quantity of the Botanical Collagen Mask at a time, domestically, and we make the next batch when the previous one is close to running out.

The practical consequences are specific. We know which batch your jar came from. When something in the formula needs adjusting, we can adjust it at the next run rather than waiting for a two-year inventory position to clear. If a botanical supplier's quality slips, we find out in weeks rather than after we've committed to a container's worth of finished product.

The tradeoff is just as specific. Producing in small quantities costs more per jar than producing in large ones, and that cost lands on the price. We're not going to tell you that small batch is cheaper or that we've found a clever way around the math. We haven't. We decided the control was worth the margin.

Botanicals are the reason the timeline matters

A formula built mostly on synthetics is stable in a way that a botanical formula isn't. Plant-derived ingredients like rosehip oil and green tea extract are more sensitive to time, light, and heat, and their character can shift from harvest to harvest in a way that a lab synthesized molecule doesn't.

That has two consequences for how we run things. The first is that we'd rather your jar be recently made than warehoused for a long stretch, which is only possible if batches are sized to sell through instead of sized for the lowest unit cost. The second is that every batch gets checked rather than assumed, because "we tested it once in development" isn't a meaningful statement about a plant derived input two years later.

There's also a preservation angle that brands don't usually discuss out loud. A product engineered to survive years of unpredictable storage needs a preservation system built for that job. Shortening the distance between production and use lets us keep the formula simpler than a long shelflife product would need to be. We still use preservation, because an unpreserved water-based cosmetic in a bathroom is a genuinely bad idea, but the requirement is different when the timeline is different.

The parts of slow that are inconvenient

Being honest about our pace means being honest about what it costs you, not just what it costs us.

Restocks will sometimes be gaps. When a batch sells through, the next one takes time to produce, and we'd rather be out of stock for a period than rush a run or pad it with a substituted ingredient. If you find something you like and then find it unavailable for a few weeks, that's the system working as designed, which is not much comfort when you're the one waiting.

The catalog will grow slowly. We launch with one product. New products will come when we're confident in them, not on a seasonal schedule, so if you're hoping we'll have a full routine soon, we probably won't.

And the price won't be the lowest available. Domestic small batch production and a shorter list of quality inputs cost what they cost. We've chosen not to close that gap by thinning the formula.

What we're not willing to speed up

There are a few places where going faster would be easy and we've ruled it out.

We won't make claims ahead of evidence to make launch marketing stronger. Our mask supports the look and feel of skin. It doesn't boost collagen production, and we won't say it does, because that's a clinical claim and we haven't done the clinical work that would justify it. Language like that would accelerate sales and we'd rather grow slower than be one more brand overstating what a cosmetic can do.

We won't launch a second product to look bigger. One considered product is more useful to you than four rushed ones, and it's more honest about the size we actually are.

We won't hide the giving back number behind a percentage. We commit a flat dollar amount from every jar sold, which means you can multiply it yourself. Percentages sound generous and can be quietly calculated from almost anything, and we'd rather be checkable than impressive.

What this means at launch

The first production run is limited by design, and we're launching in October, which puts it just ahead of the holiday season. People on the waitlist hear first, which matters more when the quantity is finite than it would if we were producing continuously.

If patience is a hard sell, we understand. Every argument in this post is also a description of why you can't buy the product right now. All we can offer against that is the thing we've been arguing for throughout, which is that you'll know what's in the jar, roughly when it was made, and what we're willing to claim about it.

You can join the waitlist at luvedacare.com. It costs nothing, and it's where the ingredient breakdowns, the launch date, and the first run details go out before they go anywhere else.